Leerink Assumes Kura Oncology (KURA) at Outperform
Tweet
Share
E-mailGet Alerts KURA Hot Sheet
Price: $12.33 --0%
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Leerink analyst Asthika Goonewardene assumes coverage on Kura Oncology (NASDAQ: KURA) with a Outperform rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Kura Oncology click here. For more ratings news on Kura Oncology click here.
Shares of Kura Oncology closed at $10.68 yesterday.
You May Also Be Interested In
- Wedbush Starts Aktis Oncology (AKTS) at Outperform
- BMO Capital Starts Aktis Oncology (AKTS) at Outperform
- BMO Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
